Gene Therapy Targeting of CNTFRa and CLC in Muscle to Treat ALS

Grants and Contracts Details


Dr. Edward J. Kasarskis will use his extensive experience in ALS basic and clinical research, as well as his ALS clinical practice experience, to advise Dr. MacLennan at all stages of the project including planning, data interpretation and manuscript preparation. This interaction will involve electronic communication, phone conversations and face to face meetings.
Effective start/end date9/15/196/30/21


  • University of Cincinnati: $18,002.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.